Tenderwize
Wróć do wyszukiwania

Open House contract for Glycopyrronium bromide/Formoterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2027 · 339 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-18 - Glycopyrroniumbromid/Formoterol (Wirkstoffkombination)

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Conclude supply contracts for pharmaceutical products relating to Glycopyrroniumbromid/Formoterol.
  • Provide the relevant medicines for the German market nationwide.
Pokaż pełne podsumowanie

Open House supply arrangement for pharmaceutical products concerning Glycopyrroniumbromid/Formoterol. The Techniker Krankenkasse seeks to conclude non-exclusive contracts with all suitable pharmaceutical companies under uniform conditions; no individual negotiations are held. The notice states that participation documents are only provided to companies that market or credibly intend to market the relevant medicines during the contract period. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. The procedure is described as not being a public procurement contract in the usual sense, so standard procurement review routes are said not to apply.

Ryzyka

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical company within the meaning of § 4 Abs. 18 AMG for the relevant medicines.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicines or otherwise be entitled to place them on the market in its own name.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open House contract for Glycopyrronium bromide/Formoterol

Supply arrangement for the drug combination Glycopyrroniumbromid/Formoterol. Scope is nationwide in Germany. The lot is an Open House Originale contract with uniform terms, no exclusivity, and no individual negotiations. The contract can be joined at any time during the contract period, subject to the stated eligibility conditions and document requirements. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jul 2025 - Jul 2027

Kategoria

Pharmaceutical products

Termin

Deadline Jul 30, 2027

Szczegóły zamówienia

Data publikacji
11 May 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
299868-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3